144 related articles for article (PubMed ID: 32430573)
1. Impact of environmental factors and physical activity on disability and quality of life in CIDP.
Doneddu PE; Bianchi E; Cocito D; Manganelli F; Fazio R; Filosto M; Beghi E; Mazzeo A; Cosentino G; Cortese A; Jann S; Clerici AM; Antonini G; Siciliano G; Marfia GA; Briani C; Lauria G; Rosso T; Cavaletti G; Carpo M; Benedetti L; Schenone A; Liberatore G; Peci E; Spina E; Tronci S; Cotti Piccinelli S; Toscano A; Gentile L; Piccolo L; Leonardi L; Mataluni G; Ruiz M; Sabatelli M; Santoro L; Nobile-Orazio E;
J Neurol; 2020 Sep; 267(9):2683-2691. PubMed ID: 32430573
[TBL] [Abstract][Full Text] [Related]
2. Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Bozovic I; Kacar A; Peric S; Nikolic A; Bjelica B; Cobeljic M; Petrovic M; Stojanov A; Djuric V; Stojanovic M; Djordjevic G; Martic V; Dominovic A; Vukojevic Z; Basta I
J Neurol; 2017 Dec; 264(12):2481-2486. PubMed ID: 29086018
[TBL] [Abstract][Full Text] [Related]
3. Prospective analysis of disability and quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Bozovic I; Peric M; Arsic Azanjac A; Palibrk A; Bulatovic I; Aleksic D; Peric S; Basta I
Qual Life Res; 2021 Sep; 30(9):2573-2579. PubMed ID: 33830457
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Serbian version of inflammatory Rasch-built overall disability scale in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Peric S; Bozovic I; Pruppers MHJ; Bjelica B; Stevic Z; Faber CG; Merkies ISJ; Basta I
J Peripher Nerv Syst; 2019 Sep; 24(3):260-267. PubMed ID: 31397933
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database.
Doneddu PE; Bianchi E; Cocito D; Manganelli F; Fazio R; Filosto M; Mazzeo A; Cosentino G; Cortese A; Jann S; Clerici AM; Antonini G; Siciliano G; Luigetti M; Marfia GA; Briani C; Lauria G; Rosso T; Cavaletti G; Carpo M; Benedetti L; Beghi E; Liberatore G; Santoro L; Peci E; Tronci S; Cotti Piccinelli S; Toscano A; Piccolo L; Verrengia EP; Leonardi L; Schirinzi E; Mataluni G; Ruiz M; Dacci P; Nobile-Orazio E;
Eur J Neurol; 2020 Jan; 27(1):136-143. PubMed ID: 31325350
[TBL] [Abstract][Full Text] [Related]
6. Neuromuscular disease-specific questionnaire to assess quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Kacar A; Bjelica B; Bozovic I; Peric S; Nikolic A; Cobeljic M; Petrovic M; Stojanov A; Djordjevic G; Vukojevic Z; Dominovic-Kovacevic A; Stojanovic M; Stevic Z; Rakocevic-Stojanovic V; Lavrnic D; Basta I
J Peripher Nerv Syst; 2018 Mar; 23(1):11-16. PubMed ID: 29360221
[TBL] [Abstract][Full Text] [Related]
7. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
[TBL] [Abstract][Full Text] [Related]
8. Employment status of patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Bjelica B; Basta I; Bozovic I; Kacar A; Nikolic A; Dominovic-Kovacevic A; Vukojevic Z; Martic V; Stojanov A; Djordjevic G; Petrovic M; Stojanovic M; Peric S
J Peripher Nerv Syst; 2018 Sep; 23(3):178-182. PubMed ID: 29999199
[TBL] [Abstract][Full Text] [Related]
9. The effect of tremor on disability assessment in chronic inflammatory demyelinating polyradiculoneuropathy.
van Veen R; Pallada G; Wieske L; Ten Holter SEM; van Rootselaar AF; Verhamme C; de Bie RMA; van Schaik IN; Merkies ISJ; Dijk JM; Eftimov F
J Peripher Nerv Syst; 2023 Mar; 28(1):58-68. PubMed ID: 36571466
[TBL] [Abstract][Full Text] [Related]
10. Chronic Acquired Polyneuropathy Patient Reported Index (CAPPRI) in chronic inflammatory demyelinating polyradiculoneuropathy.
Bjelica B; Peric S; Gwathmey K; Sadjadi R; Bozovic I; Burns TM; Basta I
J Peripher Nerv Syst; 2019 Sep; 24(3):247-252. PubMed ID: 31209940
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics, and impairment and disability scale scores for different CIDP Disease Activity Status classes.
Alabdali M; Abraham A; Alsulaiman A; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
J Neurol Sci; 2017 Jan; 372():223-227. PubMed ID: 28017218
[TBL] [Abstract][Full Text] [Related]
12. One-year follow-up study of neuropathic pain in chronic inflammatory demyelinating polyradiculoneuropathy.
Bjelica B; Peric S; Bozovic I; Kacar A; Cobeljic M; Dejanovic I; Stevic Z; Basta I
J Peripher Nerv Syst; 2019 Jun; 24(2):180-186. PubMed ID: 30973184
[TBL] [Abstract][Full Text] [Related]
13. Impairment and disability in 20 CIDP patients according to disease activity status.
Panaite PA; Renaud S; Kraftsik R; Steck AJ; Kuntzer T
J Peripher Nerv Syst; 2013 Sep; 18(3):241-6. PubMed ID: 24028192
[TBL] [Abstract][Full Text] [Related]
14. Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy.
Doneddu PE; Cocito D; Manganelli F; Fazio R; Briani C; Filosto M; Benedetti L; Bianchi E; Jann S; Mazzeo A; Antonini G; Cosentino G; Marfia GA; Cortese A; Clerici AM; Carpo M; Schenone A; Siciliano G; Luigetti M; Lauria G; Rosso T; Cavaletti G; Beghi E; Liberatore G; Santoro L; Spina E; Peci E; Tronci S; Ruiz M; Cotti Piccinelli S; Verrengia EP; Gentile L; Leonardi L; Mataluni G; Piccolo L; Nobile-Orazio E;
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1092-1099. PubMed ID: 32868387
[TBL] [Abstract][Full Text] [Related]
15. Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study.
Merkies IS; Hughes RA; Donofrio P; Bril V; Dalakas MC; Hanna K; Hartung HP; Latov N; van Doorn PA; Deng C;
J Peripher Nerv Syst; 2010 Sep; 15(3):208-15. PubMed ID: 21040143
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin.
Ryltoft AK; Al-Zuhairy A; Sindrup SH; Andersen H; Markvardsen LK
Acta Neurol Scand; 2020 Dec; 142(6):637-640. PubMed ID: 33404110
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA
Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421
[TBL] [Abstract][Full Text] [Related]
18. Fatigue in chronic inflammatory demyelinating polyneuropathy.
Gable KL; Attarian H; Allen JA
Muscle Nerve; 2020 Dec; 62(6):673-680. PubMed ID: 32710648
[TBL] [Abstract][Full Text] [Related]
19. Fatigue, Pain, Anxiety and Depression in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Merkies IS; Kieseier BC
Eur Neurol; 2016; 75(3-4):199-206. PubMed ID: 27077919
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Quality of Life in Patients With Chronic Inflammatory Demyelinating Polyneuropathy in Iran.
Okhovat AA; Gholamalizadeh S; Nafissi S; Fatehi F
J Clin Neuromuscul Dis; 2019 Dec; 21(2):77-83. PubMed ID: 31743250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
